Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma

<table>Concentration times time graph of pemetrexed in peritoneal fluid and plasma from four different pharmacologic studies. The AUC ratio of peritoneal fluid to plasma was 70. Peak plasma concentration was 0.05 (+0.02) <i>μ</i>g/mL at 30 minutes.</table>

Gastroenterology Research and Practice

fig1

Figure 1

Figure 1: Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma 

Figure 1 | Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma 